A month or so ago we interviewed the principal litigant (and whistleblower) in a lawsuit targeting alleged Medicare fraud. Today comes word that Mr Baker's efforts have captured the attention of (at least) two high-profile lawmakers:
"Senators Chuck Grassley and Max Baucus are asking the leaders of three major health insurance companies and two leading clinical laboratory testing companies for information about a practice where insurers receive discounted pricing from labs in exchange for referrals ... Grassley and Baucus said they want to “protect the interests of our nation’s Medicare and Medicaid beneficiaries and the federal health care programs.”
One supposes that this is good news (at least for Mr Baker and his supporters), but of course Medicare faces significantly more important and drastic challenges than this.
[Thanks to Ania Kapla for the tip]
"Senators Chuck Grassley and Max Baucus are asking the leaders of three major health insurance companies and two leading clinical laboratory testing companies for information about a practice where insurers receive discounted pricing from labs in exchange for referrals ... Grassley and Baucus said they want to “protect the interests of our nation’s Medicare and Medicaid beneficiaries and the federal health care programs.”
One supposes that this is good news (at least for Mr Baker and his supporters), but of course Medicare faces significantly more important and drastic challenges than this.
[Thanks to Ania Kapla for the tip]